Cost-effectiveness of the use 23-valent pneumococcal polysaccharide vaccine to prevent secondary bacterial infections related to pandemic influenza in Brazil

Autor: O’Brien, M., Dhankhar, P., Grabenstein, J., Dasbach, E.J.
Zdroj: In International Journal of Infectious Diseases 2010 14 Supplement 1:e449-e450
Databáze: ScienceDirect